CIRM Funded Clinical Trials

Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect

Disease Area:
Corneal Damage
Investigator:
Institution:
CIRM Grant:
CLIN2-14516 (Active)
Award Value:
$15,000,000.00
Trial Sponsor:
Combangio, Inc.
Trial Stage:
Phase 2
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov